These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13313524)

  • 1. Evaluation of Japanese B encephalitis vaccine. II. Serologic response following subcutaneous and intradermal administration.
    MATUMOTO M; KITAOKA M; BURNS KF
    Am J Hyg; 1956 May; 63(3):228-9. PubMed ID: 13313524
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Japanese B encephalitis vaccine. IV. Pattern of serologic response to vaccination over a five-year period in an endemic area (Okayama, Japan).
    TIGERTT WD; BERGE TO; BURNS KF; SATTERWHITE JP
    Am J Hyg; 1956 May; 63(3):238-49. PubMed ID: 13313526
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Japanese B encephalitis vaccine. III. Okayama field trial, 1946-1949.
    ANDO K; SATTERWHITE JP
    Am J Hyg; 1956 May; 63(3):230-7. PubMed ID: 13313525
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological response to Japanese B encephalitis vaccine of children and horses immune to St. Louis virus.
    HAMMON WM; SATHER GE; LENNETTE EH; REEVES WC
    Proc Soc Exp Biol Med; 1956 Mar; 91(3):517-21. PubMed ID: 13322986
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody response to intracutaneous and subcutaneous vaccination against Japanese B encephalitis.
    HU HY; LEE PH; SHIH SH
    Chin Med J; 1956; 74(5):489-95. PubMed ID: 13396888
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of attenuated strain of Japanese B encephalitis virus for possible use as a vaccine.
    ROHITAYODHIN S; HAMMON WM
    Mil Med; 1962 Jul; 127():567-8. PubMed ID: 14493409
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative safety and efficacy of subcutaneous and intradermal administration of inactivated Japanese encephalitis vaccine during predeployment preparations in the Australian Defence Force.
    Kitchener S; Nasveld P; Brennan L; Ward D
    Mil Med; 2006 Dec; 171(12):1190-5. PubMed ID: 17256680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the problem of the preparation of a tissue culture vaccine against Japanese encephalitis].
    LEVKOVICH EN; ZASUKHINA GD
    Zh Mikrobiol Epidemiol Immunobiol; 1961 May; 32():38-42. PubMed ID: 13761569
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Japanese B encephalitis vaccine. I. General background and methods.
    SABIN AB; TIGERTT WD
    Am J Hyg; 1956 May; 63(3):217-27. PubMed ID: 13313523
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental data on the effectivness of vaccination against Japanese encephalitis].
    LEVKOVICH EN
    Vopr Virusol; 1956; 1(4):39-44. PubMed ID: 13392706
    [No Abstract]   [Full Text] [Related]  

  • 11. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine.
    Hsu TC; Chow LP; Wei HY; Chen CL; Hsu ST
    Taiwan Yi Xue Hui Za Zhi; 1971 Feb; 70(2):55-62. PubMed ID: 4325804
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic studies of encephalitis in Japan. I. Hemagglutination-inhibiting, complement-fixing, and neutralizing antibody following overt Japanese B encephalitis.
    SOUTHAM CM
    J Infect Dis; 1956; 99(2):155-62. PubMed ID: 13376908
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the effect of calcium phosphate on immunogenic and antigenic properties of a vaccine against Japanese encephalitis].
    ORLOVA NN
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Mar; 30(3):95-100. PubMed ID: 13648899
    [No Abstract]   [Full Text] [Related]  

  • 15. A field trial of Japanese encephalitis vaccine produced in Thailand.
    Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
    Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
    Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on mouse brain and chick embryo tissue in connection with the preparation of Japanese encephalitis vaccine.
    ITOH H; KOBAYASHI F; TODA M; TAKASHITA I; KITAGAWA S
    Kitasato Arch Exp Med; 1953 Dec; 26(4):243-58. PubMed ID: 13286895
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination with complete adjuvant-added inactivated virus vaccine of Japanese encephalitis to swine for preventing viremia (with specific reference to the effect of vaccination on viremia; epidemiological study on Japanese encephalitis. 35).
    Ogata M; Nagao Y; Jitsunari F; Kikui R; Kitamura N
    Acta Med Okayama (1952); 1970; 24(6):579-87. PubMed ID: 4334578
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination with complete adjuvant-added inactivated virus vaccine of Japanese encephalitis to swine, rabbits and chicks for preventing viremia (epidemiological study on Japanese encephalitis 25).
    Ogata M; Nagao Y; Jitsunari F; Kitamura N
    Acta Med Okayama (1952); 1969; 23(6):541-51. PubMed ID: 4316346
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of long term cellular immune response to Japanese encephalitis vaccination using IFN-γ ELIspot assay.
    Zia A; Singh D; Saxena S; Umrao J; Baluni M; Ghildiyal S; Fatima T; Shukla M; Agarwal V; Dhole TN
    J Med Virol; 2017 Dec; 89(12):2235-2238. PubMed ID: 28671301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.